Clinical Trials on Advanced Nonhematologic Malignancies in Ireland
Total 162 results
-
AstraZenecaParexelActive, not recruitingAdvanced Haematological MalignanciesSpain, United States, Canada, Korea, Republic of, Poland, Australia, France, United Kingdom, Ireland
-
Regeneron PharmaceuticalsSanofiCompletedAdvanced Cancer | Advanced MalignanciesUnited States, Spain, Australia
-
Shanghai Junshi Bioscience Co., Ltd.Iqvia Pty Ltd; TopAlliance Biosciences, Inc.Active, not recruitingAdvanced MalignanciesUnited States
-
St. James's Hospital, IrelandIrish Cancer SocietyCompletedHematological MalignanciesIreland
-
Sigma-Tau Research, Inc.Dana-Farber Cancer Institute; Rhode Island HospitalCompletedSolid MalignanciesUnited States
-
AbbVieCompletedCancer | Advanced Solid Tumors | Hematologic MalignanciesUnited States, Japan, Netherlands, Spain
-
St Vincent's University Hospital, IrelandRecruitingLocally Advanced Rectal Cancer | Pelvic Exenteration | Advanced Pelvic MalignancyIreland
-
Regeneron PharmaceuticalsSanofiCompletedMalignanciesUnited States, Korea, Republic of, Australia, Ireland, United Kingdom
-
Precision BioSciences, Inc.RecruitingHematologic Malignancy | CD19 Expressing MalignanciesUnited States
-
PfizerActive, not recruitingOvarian Cancer | NSCLC | Solid Tumors | Urothelial Cancer | Advanced MalignanciesHungary, Spain, United States, Canada, Taiwan, Japan, Serbia, Italy, New Zealand, Australia, Mexico, Russian Federation, United Kingdom, France, Korea, Republic of, Belgium, Poland, Denmark, Israel
-
Novartis PharmaceuticalsCompletedHR+/HER2- Advanced or Metastatic Breast CancerIreland
-
Northwell HealthCompletedMediastinal Lymphadenopathy | Lung MalignanciesUnited States
-
Cancer Trials IrelandTerminatedLocally Advanced Rectal CancerIreland
-
Rhode Island HospitalBrown UniversityRecruiting
-
Rhode Island HospitalUnknownSolid Tumors | Hematological MalignanciesUnited States
-
University of Dublin, Trinity CollegeSt. James's Hospital, Ireland; Irish Cancer Society; Tallaght University Hospital and other collaboratorsCompletedBone Metastases | Advanced CancerIreland
-
Cancer Trials IrelandCompletedMetastatic Melanoma | Advanced MelanomaIreland
-
St Vincent's University Hospital, IrelandPelvEx collaborativeNot yet recruitingLocally Advanced Rectal Cancer | Recurrent Rectal Cancer | Multidisciplinary Communication | Multidisciplinary Team Meeting (MDT) | Treatment DecisionsIreland
-
Vrije Universiteit BrusselKing's College London; University of Copenhagen; Erasmus Medical Center; University... and other collaboratorsActive, not recruitingAdvanced CancerBelgium, Netherlands, Denmark, Ireland, United Kingdom, Italy
-
Bristol-Myers SquibbAgenus Inc.Active, not recruitingAdvanced CancerUnited States
-
TYK Medicines, IncRecruitingMetastatic Solid Tumor | Locally Advanced Solid TumorUnited States
-
MedImmune LLCCompletedAdvanced Solid TumorsUnited States, Australia
-
Agenus Inc.Active, not recruiting
-
MedImmune LLCCompletedAdvanced Solid TumorsUnited States, France, Spain, Switzerland
-
Cancer Trials IrelandTerminatedMetastatic Breast Cancer | HER2-positive Breast Cancer | Locally Advanced Breast Cancer | Unresectable Breast CancerIreland, Spain
-
AmgenCompletedHepatic Impairment | Solid Tumors | Hematologic MalignanciesUnited Kingdom, Netherlands, United States, France
-
Daiichi SankyoRecruitingAdvanced Solid Tumor | Metastatic Solid TumorUnited States, Japan
-
Cancer Trials IrelandCompletedAdvanced Colorectal CancerSpain, Ireland, Germany
-
Repare TherapeuticsRoche Pharma AGActive, not recruitingAdvanced Solid TumorUnited States, Canada, Denmark, United Kingdom
-
Repare TherapeuticsDebiopharm International SARecruitingAdvanced Solid TumorUnited States, Canada, Denmark
-
Cancer Trials IrelandCompleted
-
BayerActive, not recruitingAdvanced Solid TumorsUnited States, Singapore, Italy, United Kingdom
-
Hoffmann-La RocheRecruitingAdvanced Solid TumorsUnited States
-
Eli Lilly and CompanyCompletedAdvanced CancerPuerto Rico, United States
-
Jiangsu HengRui Medicine Co., Ltd.RecruitingAdvanced Solid TumorsUnited States, Korea, Republic of, Australia
-
MedImmune LLCCompletedA Study of MEDI5395 in Combination With Durvalumab in Participants With Select Advanced Solid TumorsAdvanced Solid TumorsUnited States, United Kingdom
-
Dartmouth-Hitchcock Medical CenterNational Institute of Nursing Research (NINR)Completed
-
Pyxis Oncology, IncRecruiting
-
Chugai PharmaceuticalRecruitingLocally Advanced or Metastatic Solid TumorsUnited States, Japan
-
Adam OlszewskiActive, not recruitingLymphoma | Acute Myeloid Leukemia | Myelodysplastic Syndromes | Leukemia | Hematologic Malignancy | MyelomaUnited States
-
Cancer Trials IrelandCompleted
-
Ningbo Newbay Technology Development Co., LtdRecruitingAdvanced Solid TumorUnited States, China, Korea, Republic of, Spain, France, United Kingdom
-
ModernaTX, Inc.TerminatedOvarian Cancer | Relapsed/Refractory Solid Tumor Malignancies or LymphomaUnited States
-
Brown UniversityRhode Island HospitalCompletedPancreatic Cancer | Locally Advanced Pancreatic CancerUnited States
-
MedImmune LLCActive, not recruitingSelected Advanced Solid TumorsItaly, Spain, United States, France, Korea, Republic of, Taiwan, Australia, Netherlands, Portugal
-
AstraZenecaRecruitingAdvanced Solid Tumours That Are MTAP DeficientUnited States, Spain, Korea, Republic of, Australia, Japan, China, Netherlands, France
-
Astellas Pharma Global Development, Inc.Active, not recruiting
-
Novartis PharmaceuticalsTerminatedSolid Tumor | Hematologic MalignanciesUnited States
-
Daiichi SankyoAstraZenecaRecruitingBreast Cancer | Advanced Solid TumorUnited States, Spain, Canada, France
-
MedImmune LLCActive, not recruitingAdvanced Solid TumorsUnited States, Spain, Belgium, Italy, Korea, Republic of, Canada, Australia, Hungary, United Kingdom, France, New Zealand